FLT3 and acute myeloid leukemia: Our data illustrated no significant differences in the total percentages of NK cells between our three groups; only the in-depth analysis of AML cases revealed a heterogeneous distribution, with extreme values, as represented by the cases with FLT3-ITD, NPM1, and IDH2 mutations.